Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in Type 2 diabetes.

被引：0
|
作者：
Lautamäki, RM
Iozzo, P
Hällsten, K
Virtanen, KA
Kemppainen, J
Lönnqvist, F
Ferrannini, E
Knuuti, J
Nuutila, P
机构：
[1] Turku PET Ctr, Turku, Finland
[2] CNR, Natl Res Council, Inst Clin Physiol, I-56100 Pisa, Italy
[3] Karolinska Inst, Huddinge Univ Hosp, S-10401 Stockholm, Sweden
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
172
引用
收藏
页码：A62 / A62
页数：1
相关论文
共 50 条
  • [1] Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes
    Iozzo, P
    Hallsten, K
    Oikonen, V
    Virtanen, KA
    Parkkola, R
    Kemppainen, J
    Solin, O
    Lonnqvist, F
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    [J]. DIABETES CARE, 2003, 26 (07) : 2069 - 2074
  • [2] Effects of metformin and rosiglitazone monotherapy on insulin mediated hepatic glucose uptake, and their relation to visceral fat in type 2 diabetes
    Iozzo, P
    Hallsten, K
    Oikonen, V
    Virtanen, K
    Parkkola, R
    Kemppainen, J
    Solin, O
    Lonnqvist, F
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    [J]. DIABETES, 2003, 52 : A76 - A76
  • [3] Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: Evidence for a relationship with glycemic control
    Iozzo, P
    Hallsten, K
    Oikonen, V
    Virtanen, KA
    Kemppainen, J
    Solin, O
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05): : 2055 - 2060
  • [4] Rosiglitazone but not metformin enhances insulin stimulated myocardial glucose uptake in patients with type 2 diabetes
    Nuutila, P
    Hällsten, K
    Virtanen, KA
    Lönnqvist, F
    Viikari, J
    Rönnemaa, T
    Knuuti, J
    [J]. DIABETES, 2002, 51 : A142 - A142
  • [5] Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in Type 2 diabetes
    Virtanen, KA
    Hällsten, K
    Parkkola, R
    Lönnqvist, F
    Lönnroth, P
    Rönnemaa, T
    Knuuti, J
    Huupponen, R
    Nuutila, P
    [J]. DIABETOLOGIA, 2002, 45 : A251 - A251
  • [6] Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes
    Yuan, MS
    Melendez, PA
    Iwamoto, M
    Lee, JS
    Shoelson, SE
    [J]. DIABETES, 2002, 51 : A145 - A145
  • [7] Oxygen uptake in subcutaneous adipose tissue in type 2 diabetes: relation to perfusion and insulin-mediated glucose uptake and response to exercise
    Bucci, M.
    Virtanen, K. A.
    Viljanen, A.
    Honka, M. J.
    Landini, L.
    Oikonen, V.
    Ferrannini, E.
    Nuutila, P.
    Iozzo, P.
    [J]. DIABETOLOGIA, 2016, 59 : S289 - S289
  • [8] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Yilmaz, Hamiyet
    Gursoy, Alptekin
    Sahin, Mustafa
    Demirag, Nilgun Guvener
    [J]. ACTA DIABETOLOGICA, 2007, 44 (04) : 187 - 192
  • [9] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Hamiyet Yilmaz
    Alptekin Gursoy
    Mustafa Sahin
    Nilgun Guvener Demirag
    [J]. Acta Diabetologica, 2007, 44 : 187 - 192
  • [10] Reduced insulin-mediated glucose uptake by euglycemic clamp in offspring of patients with type 2 diabetes
    Strojek, K
    Grzeszczak, W
    Morawin, E
    Adamski, M
    Lacka, B
    Ritz, E
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (06) : 470 - 474
12345